STOCK TITAN

Vanguard disaggregates holdings; MannKind (MNKD) shows 0 shares in 13G/A

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

MannKind Corp — Amendment No. 4 to a Schedule 13G/A filed by The Vanguard Group reports beneficial ownership of 0 shares representing 0% of Common Stock. The filing notes an internal realignment effective January 12, 2026 under SEC Release No. 34-39538 that prompted disaggregated reporting by certain Vanguard subsidiaries. The report is signed by Ashley Grim on March 27, 2026, and states Vanguard entities have the right to receive dividends or proceeds for managed accounts, while no single outside person holds more than 5%.

Positive

  • None.

Negative

  • None.

Insights

Vanguard disaggregated holdings; reported zero beneficial ownership in MannKind.

The filing records 0 shares and 0% ownership after an internal reorganization described as effective January 12, 2026. This is a reporting change tied to organizational structure rather than a market trade.

Operationally, the filing indicates separate subsidiary reporting under SEC Release No. 34-39538; subsequent filings from Vanguard entities may show where beneficial positions are now reported.

Amendment clarifies reporting lines in reliance on SEC release; no control or dispositive power shown.

The statement explains that certain Vanguard subsidiaries will report beneficial ownership separately and that The Vanguard Group no longer is "deemed to have" ownership of those subsidiary-held securities under the cited release.

Signatures and the amendment date (March 27, 2026) complete the disclosure; cash‑flow treatment or specific subsidiary holdings are not listed in this excerpt.






56400P706

(CUSIP Number)
03/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/27/2026

FAQ

Who filed the Schedule 13G/A for MannKind (MNKD)?

The filing was made by The Vanguard Group. The Schedule 13G/A Amendment No. 4 is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.

How many MannKind shares does Vanguard report owning?

Vanguard reports owning 0 shares of MannKind Common Stock. The filing explicitly lists Amount beneficially owned: 0 and Percent of class: 0% in Item 4.

Why does the Schedule 13G/A show 0% ownership for Vanguard?

Because Vanguard disaggregated holdings after an internal realignment effective January 12, 2026, and certain subsidiaries now report separately under SEC Release No. 34-39538.

Does this filing indicate Vanguard controls MannKind shares for managed accounts?

The filing states Vanguard entities have rights to receive dividends or proceeds for managed accounts, but it reports no sole or shared voting/dispositive power and lists zero shares in Item 4.

When did Vanguard change its reporting structure for these holdings?

The internal realignment occurred on January 12, 2026, and the amendment references SEC Release No. 34-39538 as the basis for separate subsidiary reporting going forward.
Mannkind

NASDAQ:MNKD

View MNKD Stock Overview

MNKD Rankings

MNKD Latest News

MNKD Latest SEC Filings

MNKD Stock Data

702.47M
298.20M
Biotechnology
Pharmaceutical Preparations
Link
United States
DANBURY